COVID-19 report shares insights on potential therapies
A new scientific report offers a comprehensive review of protein targets, associated COVID-19 drug candidates to date and other revealing information.
A new scientific report offers a comprehensive review of protein targets, associated COVID-19 drug candidates to date and other revealing information.
The pharma firm and health association plan to collaborate in order to help drive global action toward prevention and control of cardiovascular disease.
The risk-based quality management specialist has landed a minority investment from the growth equity firm with $21b in asssets under management.